Genemod AI
Resources
top-10-scispot-alternatives-more-operational-lims-platform-to-watch-in-2026

Top 10 SciSpot Alternatives: More Operational LIMS Platforms to Watch in 2026

Looking for SciSpot alternatives in 2026? Discover why labs outgrow ELN-first platforms and why Genemod is the strongest operational LIMS for scaling R&D teams.

All
Data Management
Scientific Research
What's new
Events
top-10-scispot-alternatives-more-operational-lims-platform-to-watch-in-2026

Top 10 SciSpot Alternatives: More Operational LIMS Platforms to Watch in 2026

Looking for SciSpot alternatives in 2026? Discover why labs outgrow ELN-first platforms and why Genemod is the strongest operational LIMS for scaling R&D teams.
January 16, 2026
top-10-biotech-companies-in-australia-to-watch-leading-into-2026

Top 10 Biotech Companies in Australia to Watch Leading Into 2026

Australia’s biotech sector is gaining global momentum. Explore 10 Australia-headquartered biotech companies to watch leading into 2026, spanning radiopharma, cell therapy, oncology, and specialty biopharma.
January 16, 2026
top-10-starlims-alternatives-for-modern-labs-in-2026

Top 10 STARLIMS Alternatives for Modern Labs in 2026

Looking for STARLIMS alternatives in 2026? Explore why labs are moving away from legacy LIMS and why Genemod stands out as the most modern, scalable replacement for growing R&D teams.
January 16, 2026
why-do-labs-keep-losing-track-of-samples-after-they-scale

Why Do Labs Keep Losing Track of Samples After They Scale?

As labs scale, samples don’t disappear—they become untraceable. Discover why sample tracking breaks down after growth and how a modern LIMS like Genemod prevents operational drift.
January 12, 2026
top-10-biotech-companies-in-japan-to-watch-leading-into-2026

Top 10 Biotech Companies in Japan to Watch Leading Into 2026

Japan’s biotech sector is entering 2026 with momentum in regenerative medicine, peptide and RNA platforms, and advanced biomanufacturing. Discover 10 Japan-headquartered biotech companies to watch.
January 09, 2026
JPM2026_Genemod

JPM2026: What it Reveals About the Next Phase of Biopharma Scaling

JPM2026 highlights a new era of biopharma scaling focused on execution discipline, platform industrialization, and operational maturity. Learn what the conference reveals about the future of R&D growth.
January 09, 2026